DCM
DAFNA Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Sell |
218,255
-340,000
| -61% | -$3.05M | 0.54% | 38 |
|
|
2025
Q1 | $4.19M | Sell |
558,255
-108,745
| -16% | -$816K | 1.19% | 24 |
|
|
2024
Q4 | $5.02M | Hold |
667,000
| – | – | 1.28% | 21 |
|
|
2024
Q3 | $5.07M | Sell |
667,000
-37,500
| -5% | -$285K | 1.2% | 23 |
|
|
2024
Q2 | $4.35M | Sell |
704,500
-5,000
| -0.7% | -$30.9K | 1.04% | 27 |
|
|
2024
Q1 | $3.6M | Hold |
709,500
| – | – | 0.82% | 33 |
|
|
2023
Q4 | $4.25M | Buy |
709,500
+57,500
| +9% | +$344K | 1.02% | 33 |
|
|
2023
Q3 | $4.62M | Buy |
652,000
+83,000
| +15% | +$588K | 1.44% | 22 |
|
|
2023
Q2 | $4.01M | Buy |
569,000
+17,500
| +3% | +$123K | 1.1% | 29 |
|
|
2023
Q1 | $4.6M | Buy |
551,500
+300,500
| +120% | +$2.51M | 1.38% | 25 |
|
|
2022
Q4 | $2.88M | Buy |
+251,000
| New | +$2.88M | 0.81% | 37 |
|
|
2020
Q4 | – | Sell |
-749,051
| Closed | -$2.57M | – | 79 |
|
|
2020
Q3 | $2.57M | Buy |
749,051
+5,000
| +0.7% | +$17.2K | 0.84% | 36 |
|
|
2020
Q2 | $3.55M | Buy |
744,051
+265,000
| +55% | +$1.26M | 1.02% | 30 |
|
|
2020
Q1 | $958K | Sell |
479,051
-35,000
| -7% | -$70K | 0.4% | 49 |
|
|
2019
Q4 | $1.77M | Buy |
514,051
+30,663
| +6% | +$106K | 0.61% | 38 |
|
|
2019
Q3 | $1.39M | Buy |
483,388
+72,500
| +18% | +$208K | 0.52% | 50 |
|
|
2019
Q2 | $1.56M | Sell |
410,888
-87,527
| -18% | -$332K | 0.59% | 48 |
|
|
2019
Q1 | $4.06M | Buy |
498,415
+34,000
| +7% | +$277K | 1.75% | 19 |
|
|
2018
Q4 | $3.75M | Sell |
464,415
-187,671
| -29% | -$1.51M | 1.86% | 18 |
|
|
2018
Q3 | $4.98M | Buy |
652,086
+47,434
| +8% | +$362K | 2.04% | 15 |
|
|
2018
Q2 | $3.47M | Sell |
604,652
-370,000
| -38% | -$2.12M | 1.62% | 21 |
|
|
2018
Q1 | $4.65M | Sell |
974,652
-218,576
| -18% | -$1.04M | 2.26% | 15 |
|
|
2017
Q4 | $5.86M | Hold |
1,193,228
| – | – | 3.16% | 7 |
|
|
2017
Q3 | $6.25M | Buy |
1,193,228
+602,100
| +102% | +$3.16M | 3.88% | 5 |
|
|
2017
Q2 | $3.29M | Buy |
591,128
+50,000
| +9% | +$278K | 2.35% | 7 |
|
|
2017
Q1 | $4.55M | Buy |
541,128
+475,228
| +721% | +$3.99M | 3.84% | 5 |
|
|
2016
Q4 | $417K | Buy |
+65,900
| New | +$417K | 0.37% | 55 |
|
|
2016
Q2 | – | Sell |
-149,642
| Closed | -$423K | – | 96 |
|
|
2016
Q1 | $423K | Sell |
149,642
-106,000
| -41% | -$300K | 0.36% | 67 |
|
|
2015
Q4 | $2.64M | Sell |
255,642
-3,000
| -1% | -$31K | 2.35% | 13 |
|
|
2015
Q3 | $2.95M | Buy |
258,642
+36,986
| +17% | +$422K | 2.93% | 6 |
|
|
2015
Q2 | $3.31M | Buy |
221,656
+55,000
| +33% | +$821K | 2.8% | 7 |
|
|
2015
Q1 | $1.51M | Hold |
166,656
| – | – | 1.16% | 25 |
|
|
2014
Q4 | $2.03M | Buy |
166,656
+90,256
| +118% | +$1.1M | 1.6% | 19 |
|
|
2014
Q3 | $747K | Buy |
+76,400
| New | +$747K | 0.75% | 32 |
|